- Home
- WKEY vs MAIA Comparison
WKEY vs MAIA Comparison
Compare WKEY & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- MAIA
- Stock Information
- Founded
- WKEY 1999
- MAIA 2018
- Country
- WKEY Switzerland
- MAIA United States
- Employees
- WKEY N/A
- MAIA N/A
- Industry
- WKEY EDP Services
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- MAIA Health Care
- Exchange
- WKEY Nasdaq
- MAIA Nasdaq
- Market Cap
- WKEY 58.9M
- MAIA 56.3M
- IPO Year
- WKEY N/A
- MAIA 2022
- Fundamental
- Price
- WKEY $6.94
- MAIA $1.73
- Analyst Decision
- WKEY Strong Buy
- MAIA
- Analyst Count
- WKEY 2
- MAIA 0
- Target Price
- WKEY $7.50
- MAIA N/A
- AVG Volume (30 Days)
- WKEY 167.8K
- MAIA 529.9K
- Earning Date
- WKEY 09-23-2025
- MAIA 11-11-2025
- Dividend Yield
- WKEY N/A
- MAIA N/A
- EPS Growth
- WKEY N/A
- MAIA N/A
- EPS
- WKEY N/A
- MAIA N/A
- Revenue
- WKEY $11,994,000.00
- MAIA N/A
- Revenue This Year
- WKEY $32.29
- MAIA N/A
- Revenue Next Year
- WKEY $89.83
- MAIA N/A
- P/E Ratio
- WKEY N/A
- MAIA N/A
- Revenue Growth
- WKEY N/A
- MAIA N/A
- 52 Week Low
- WKEY $1.61
- MAIA $1.40
- 52 Week High
- WKEY $14.00
- MAIA $3.48
- Technical
- Relative Strength Index (RSI)
- WKEY 64.99
- MAIA 57.95
- Support Level
- WKEY $6.25
- MAIA $1.53
- Resistance Level
- WKEY $6.77
- MAIA $1.88
- Average True Range (ATR)
- WKEY 0.54
- MAIA 0.09
- MACD
- WKEY 0.08
- MAIA 0.02
- Stochastic Oscillator
- WKEY 73.53
- MAIA 58.33
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.